Otomycosis with Perforated Tympanic Membrane: Self medication with Topical Antifungal Solution versus Medicated Ear Wick
- PMID: 23267306
- PMCID: PMC3523785
- DOI: 10.12816/0005975
Otomycosis with Perforated Tympanic Membrane: Self medication with Topical Antifungal Solution versus Medicated Ear Wick
Abstract
Objectives: In otomycosis with tympanic membrane perforation, many physicians prefer to insert an ear wick medicated with antimycotic cream. This needs multiple visits to the clinic and keeps the ear blocked for several days. Direct instillation of alcohol based antimycotic solution causes severe burning if it reaches the middle ear. In this work we compare patient's self medication with clotrimazole antimycotic solution used on Q-tips with physician-inserted ear wicks; in terms of safety, efficacy and patient satisfaction. STUDY DESIGN #ENTITYSTARTX00026;
Setting: Prospective controlled study in ambulatory setting.
Methodology: Forty consecutive patients with otomycosis with tympanic membrane perforation were included in the study. Diagnosis of otomycosis was both clinical and with mycological culture. Mean pure tone average (PTA) in the involved ear was measured after cleaning fungal debris. Patients were then, randomized into two groups; Q-tip group patients (n=20) were taught to self-medicate their ears two times daily with the clotrimazole solution on suitable Q-tips for three weeks. In ear wick group (n=20), a gauze wick impregnated with clotrimazole cream was inserted in the ear. Wick was changed every third day for two more visits (one week overall). Patients were followed up for 3 months.
Results: After three weeks all patients in Q-tip group and ear wick group had relief of their ear itching and complete disappearance of fungal growth in the deep meatus and on the tympanic membrane. PTA was 22 ± 11dB in Q-tip group and 25 ± 12 dB in ear wick group; the difference was not statistically significant (p= 0.11). Patients in ear wick group had sense of ear blocking and wetness during period of treatment. Transient burning sensation was reported by 2 patients in Q-tip group. During three months, there was recurrence of otomycosis in 5 patients from ear wick group and no recurrence in Q-tip group (p=0.04).
Conclusion: Self medication with clotrimazole solution on Q-tips and physician inserted medicated wicks are equally safe in treating otomycosis with perforated tympanic membrane. However, self medication with antimycotic solution on Q-tips gives more patient satisfaction and less rate of otomycosis recurrence.
Keywords: clotrimazole; ear external; topical; tympanic membrane perforation.
Similar articles
-
Treatment of Otomycosis in Ears with Tympanic Membrane Perforation is Easier with Paper Patch.Turk Arch Otorhinolaryngol. 2019 Dec;57(4):182-186. doi: 10.5152/tao.2019.4384. Epub 2019 Dec 1. Turk Arch Otorhinolaryngol. 2019. PMID: 32128515 Free PMC article.
-
Fungal otitis externa and tympanic membrane perforation.Indian J Otolaryngol Head Neck Surg. 2023 Apr;75(Suppl 1):1-5. doi: 10.1007/s12070-022-03132-y. Epub 2022 Aug 2. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37206775 Free PMC article.
-
Pooled Analysis of 2 Randomized Clinical Trials to Evaluate the Efficacy and Safety of Clotrimazole 1% Otic Solution for the Treatment of Otomycosis in Adults.J Otolaryngol Head Neck Surg. 2025 Jan-Dec;54:19160216251330629. doi: 10.1177/19160216251330629. Epub 2025 Apr 15. J Otolaryngol Head Neck Surg. 2025. PMID: 40231796 Free PMC article. Clinical Trial.
-
[Antimycotic therapy in otomycosis with tympanic membrane perforation].HNO. 2000 Jan;48(1):18-21. doi: 10.1007/s001060050003. HNO. 2000. PMID: 10663044 Review. German.
-
Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study.Mycopathologia. 2022 Jun;187(2-3):225-233. doi: 10.1007/s11046-022-00626-9. Epub 2022 Mar 26. Mycopathologia. 2022. PMID: 35347533 Review.
Cited by
-
Effect of combination therapy with ceftizoxime and clotrimazole in the treatment of otomycosis.Curr Med Mycol. 2018 Mar;4(1):18-23. doi: 10.18502/cmm.4.1.30. Curr Med Mycol. 2018. PMID: 30186989 Free PMC article.
-
Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification.Int J Microbiol. 2014;2014:636493. doi: 10.1155/2014/636493. Epub 2014 May 18. Int J Microbiol. 2014. PMID: 24949016 Free PMC article.
-
Nanocrystalline Silver for the Treatment of Otomycosis: A Retrospective Study.Iran J Otorhinolaryngol. 2023 Mar;35(127):83-89. doi: 10.22038/IJORL.2023.66805.3303. Iran J Otorhinolaryngol. 2023. PMID: 37223402 Free PMC article.
-
Assessment of Response to Treatment in Patients with Otomycosis.Iran J Otorhinolaryngol. 2018 Jan;30(96):41-47. Iran J Otorhinolaryngol. 2018. PMID: 29387663 Free PMC article.
-
Approach to otitis externa.Can Fam Physician. 2024 Oct;70(10):617-623. doi: 10.46747/cfp.7010617. Can Fam Physician. 2024. PMID: 39406431 Free PMC article. Review.
References
-
- Paulose KO, Al Khalifa S, Shenoy P, Sharma RK. Mycotic infection of the ear (otomycosis): a prospective study. J Laryngol Otol. 1989;103:30–5. - PubMed
-
- Pradhan B, Tuladhar NR, Amatya RM. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Ann OtolRhinolLaryngol. 2003;112:384–7. - PubMed
-
- Jackman A, Ward R, April M, Bent J. Topical antibiotic induced otomycosis. Int J PediatrOtorhinolaryngol. 2005;69:857–60. - PubMed
-
- Kaya AD, Kiraz N. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Mycoses. 2007;50:447–50. - PubMed
-
- Araiza J, Canseco P, Bonifaz A. Otomycosis: clinical and mycological study of 97 cases. Rev LaryngolOtolRhinol (Bord) 2006;127:251–4. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous